Veradermics Inc
MANE
Company Profile
Business description
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Contact
470 James Street
New HavenCT06513
USAT: +1 228 372-3376
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
Cheap Narrow Moat ASX share continues to face negative sentiment
Earnings growth fails to excite investors worried about AI disruption.
stocks
ASX energy giant remains cheap following record production
Impressive cost control and record production leads to higher dividend.
stocks
Strong results from cheap ASX share
The market responded favourably to results but shares still underpriced.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,359.00 | 50.70 | 0.54% |
| CAC 40 | 8,543.93 | 24.72 | 0.29% |
| DAX 40 | 25,072.35 | 86.10 | 0.34% |
| Dow JONES (US) | 49,174.50 | 370.44 | 0.76% |
| FTSE 100 | 10,781.64 | 101.05 | 0.95% |
| HKSE | 26,765.72 | 175.40 | 0.66% |
| NASDAQ | 22,863.68 | 236.41 | 1.04% |
| Nikkei 225 | 58,583.12 | 1,262.03 | 2.20% |
| NZX 50 Index | 13,525.58 | 6.73 | -0.05% |
| S&P 500 | 6,890.07 | 52.32 | 0.77% |
| S&P/ASX 200 | 9,128.30 | 44.20 | 0.49% |
| SSE Composite Index | 4,147.23 | 29.82 | 0.72% |